시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
아나필락시스 치료 시장 보고서(2025년)
Anaphylaxis Treatment Global Market Report 2025
상품코드 : 1824329
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 아나필락시스 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 7.1%로 확대되어 86억 8,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 생물학적 요법의 혁신, 맞춤형 치료 접근법, 식품 안전에 대한 세계적인 노력, 환자의 강화 및 광고, 응급 의료 서비스의 강화 등에 기인할 수 있습니다. 예측기간의 주요 동향으로는 자동주사기의 기술 혁신, 아나필락시스 관리를 위한 원격의료, 알레르겐 면역요법의 개선, 알레르겐 검출을 위한 생체인증 웨어러블, 알레르기 연구에서의 공동연구 등이 있습니다.

향후 5년간의 성장률 7.1%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세의 상승은 독일과 덴마크에서 조달하는 프리필드 에피네프린 주사기 및 긴급 기도 기구의 가격을 밀어 올리고 구명 처치를 위한 자기 부담 비용을 악화시킴으로써 미국의 알레르기 환자에게 부담을 강하게 할 가능성이 높습니다. 이 영향은 또한 상호관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향에 의해 더욱 널리 느껴질 수 있습니다.

식품 알레르기의 유병률 증가는 아나필락시스 치료 시장의 성장을 가속할 것으로 예측됩니다. 식품 알레르기는 음식의 단백질에 의해 야기되는 면역 반응을 의미합니다. 아나필락시스 치료는 피부, 점막 표면, 호흡 기능, 혈압, 중요 기관에 영향을 미치는 생명을 위협하는 알레르기 반응의 진행을 막는 데 매우 중요합니다. 예를 들어, 2023년 1월 미국 정부 기관인 질병 대책 예방 센터(CDC)는 2021년 18세 이상의 성인의 31.8%가 습진, 계절성 알레르기, 식품 알레르기를 경험했다고 보고했습니다. 이 중 계절성 알레르기는 25.7%, 식품 알레르기는 6.2%, 습진은 7.3%였습니다. 또한 2024년 8월 영국 비부처인 식품기준청은 2021년 10월부터 2023년 8월 27일 사이에 296건의 유효한 사례 보고가 레지스트리에 제출되었음을 밝혔습니다. 이 보고서는 영국에서 우발적 반응의 5% 이하를 반영했을 가능성이 높고, 213건(72%)이 식품 유인에 기인하고, 208건(97.7%)이 18세 이하의 개인에서 발생하고 있으며, 플랫폼 접근에 등록되어 있는 것은 28개 클리닉과 11개 사고 구급(A&E)부가 있었습니다. 따라서 식품 알레르기의 유병률 증가는 아나필락시스 치료 시장의 성장을 이끌고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Anaphylaxis treatment involves addressing life-threatening allergic reactions to allergens such as foods, insect stings, medications, and latex. Immediate administration of epinephrine is crucial to counteract the allergic response and stabilize the patient's condition. Effective management of anaphylaxis requires rapid medical intervention and comprehensive supportive care to alleviate potentially life-threatening symptoms.

Key treatments for anaphylaxis include epinephrine, antihistamines, steroids, beta-antagonists, and other supportive measures. Epinephrine, a synthetic or extracted form of adrenaline, is the primary and essential therapy for anaphylaxis. It must be administered promptly upon identifying the condition to prevent the onset of severe symptoms. These treatments are available in various forms such as tablets and capsules and are distributed through hospital pharmacies, retail pharmacies, and online platforms, addressing allergies such as food allergies, pollen allergies, dust mite allergies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The anaphylaxis treatment market research report is one of a series of new reports from The Business Research Company that provides anaphylaxis treatment market statistics, including anaphylaxis treatment industry global market size, regional shares, competitors with an anaphylaxis treatment market share, detailed anaphylaxis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis treatment industry. This anaphylaxis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anaphylaxis treatment market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.59 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, healthcare professional training.

The anaphylaxis treatment market size is expected to see strong growth in the next few years. It will grow to $8.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, collaborations in allergy research.

The forecast of 7.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. allergy patients by driving up the cost of prefilled epinephrine syringes and emergency airway devices sourced from Germany and Denmark, exacerbating out-of-pocket costs for life-saving interventions. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of food allergies is expected to drive the growth of the anaphylaxis treatment market. Food allergy refers to an immune response triggered by proteins in food. Anaphylaxis treatment is crucial in preventing the progression of life-threatening allergic reactions that affect the skin, mucosal surfaces, respiratory function, blood pressure, and vital organs. For instance, in January 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that in 2021, 31.8% of adults aged 18 and older experienced eczema, a seasonal allergy, or a food allergy. Among these, 25.7% had a seasonal allergy, 6.2% had a food allergy, and 7.3% had eczema. Additionally, in August 2024, the Food Standards Agency, a UK-based non-ministerial department, revealed that 296 valid case reports were submitted to the Registry between October 2021 and August 27, 2023. These reports likely reflect less than 5% of accidental reactions in the UK, with 213 (72%) attributed to food triggers and 208 (97.7%) occurring in individuals aged 18 or younger, with only 28 clinics and 11 Accident & Emergency (A&E) departments registered for access to the platform. Thus, the increasing prevalence of food allergies is driving the growth of the anaphylaxis treatment market.

The growth of the anaphylaxis treatment market is also expected to be driven by rising healthcare expenditure. Healthcare expenditure refers to the total spending on healthcare goods and services over a specific period, typically at the national level or within a healthcare system. Increased healthcare spending improves access to anaphylaxis treatment options, ensuring timely availability of life-saving medications, fostering research and development efforts, creating alternative treatment options, improving emergency response systems, and implementing preventive measures. For example, in September 2024, the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, reported that US healthcare expenditure grew by 4.1% in 2022, reaching $4.5 trillion, equivalent to $13,493 per person and representing 17.3% of the nation's gross domestic product. Therefore, the increase in healthcare expenditure is contributing to the growth of the anaphylaxis treatment market.

Advancements in product development mark a significant trend in the anaphylaxis treatment market. Major industry players are intensifying their product innovations to maintain a competitive edge. For example, in April 2022, Aquestive Therapeutics Inc., a US-based pharmaceutical firm, secured Fast Track designation from the Food and Drug Administration for AQST-109, an orally administered epinephrine product candidate designed for treating severe allergic responses, including anaphylaxis. This pioneering solution is a notable milestone, showing comparable clinical outcomes to autoinjectors such as EpiPen and Auvi-Q in managing allergic emergencies.

Companies at the forefront of the anaphylaxis treatment market are prioritizing innovative solutions such as the sulfite-free epinephrine injection to drive market growth. This injection, a crucial life-saving medication for severe allergic reactions, has witnessed advancements in its formulations. For instance, in March 2023, American Regent Inc., a leading US-based pharmaceutical company, launched a sulfite-free epinephrine injection USP. This product, suitable for subcutaneous, intramuscular, and intravenous administration, boasts a formulation devoid of sulfites or preservatives. Notably, it's recommended for adult patients experiencing hypotension due to septic shock to elevate mean arterial blood pressure.

In October 2023, the US-based biopharmaceutical company Amgen Inc. completed the acquisition of Horizon Therapeutics Plc for a substantial sum of $27.8 billion. This strategic move positions Amgen to expand its product portfolio, enabling the company to provide treatments for severe inflammatory, autoimmune, and rare disorders. The acquisition underscores Amgen's commitment to leveraging biotechnology to address the healthcare needs of patients facing life-threatening conditions. Horizon Therapeutics PLC, based in Ireland, is a biopharmaceutical company with a focus on developing innovative therapeutic solutions.

Major companies operating in the anaphylaxis treatment market include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abello A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, Impax Laboratories LLC

North America was the largest region in the anaphylaxis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anaphylaxis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anaphylaxis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anaphylaxis treatment market consists of sales of bronchodilators, corticosteroids, and vasopressors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anaphylaxis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anaphylaxis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for anaphylaxis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anaphylaxis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Anaphylaxis Treatment Market Characteristics

3. Anaphylaxis Treatment Market Trends And Strategies

4. Anaphylaxis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Anaphylaxis Treatment Growth Analysis And Strategic Analysis Framework

6. Anaphylaxis Treatment Market Segmentation

7. Anaphylaxis Treatment Market Regional And Country Analysis

8. Asia-Pacific Anaphylaxis Treatment Market

9. China Anaphylaxis Treatment Market

10. India Anaphylaxis Treatment Market

11. Japan Anaphylaxis Treatment Market

12. Australia Anaphylaxis Treatment Market

13. Indonesia Anaphylaxis Treatment Market

14. South Korea Anaphylaxis Treatment Market

15. Western Europe Anaphylaxis Treatment Market

16. UK Anaphylaxis Treatment Market

17. Germany Anaphylaxis Treatment Market

18. France Anaphylaxis Treatment Market

19. Italy Anaphylaxis Treatment Market

20. Spain Anaphylaxis Treatment Market

21. Eastern Europe Anaphylaxis Treatment Market

22. Russia Anaphylaxis Treatment Market

23. North America Anaphylaxis Treatment Market

24. USA Anaphylaxis Treatment Market

25. Canada Anaphylaxis Treatment Market

26. South America Anaphylaxis Treatment Market

27. Brazil Anaphylaxis Treatment Market

28. Middle East Anaphylaxis Treatment Market

29. Africa Anaphylaxis Treatment Market

30. Anaphylaxis Treatment Market Competitive Landscape And Company Profiles

31. Anaphylaxis Treatment Market Other Major And Innovative Companies

32. Global Anaphylaxis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anaphylaxis Treatment Market

34. Recent Developments In The Anaphylaxis Treatment Market

35. Anaphylaxis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기